Category
December 6, 2018
Sometimes small things make the biggest difference. A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene are able to kill medulloblastoma, the most common childhood brain cancer.
December 4, 2018
John Paul Spence 1, Jill L Reiter 1, Bin Qiu 2, Hao Gu 2, Dawn K Garcia 3, Lingling Zhang 2, Tamara Graves 1, Kent E Williams 1, Paula J Bice 4, Yi Zou 3, Zhao Lai 4, Weidong Yong 2, Tiebing Liang 1 Abstract Humans show sex differences related to alcohol use disorders (AUD). Animal model research has the potential to provide important insight into how sex differences affect alcohol consumption, particularly because female animals frequently drink more than […]
December 1, 2018
Michele Dowless, Caitlin D. Lowery, Terry Shackleford, Matthew Renschler, Jennifer Stephens, Robert Flack, Wayne Blosser, Simone Gupta, Julie Stewart, Yue Webster, Jack Dempsey, Alle B. VanWye, Philip Ebert, Philip Iversen, Jonathan B. Olsen, Xueqian Gong, Sean Buchanan, Peter Houghton, and Louis Stancato Abstract Purpose: Ewing sarcoma (ES) is a rare and highly malignant cancer that occurs in the bone and surrounding tissue of children and adolescents. The EWS/ETS fusion transcription factor that drives ES pathobiology was previously demonstrated to modulate cyclin D1 expression. In this study, we evaluated abemaciclib, a small-molecule CDK4, and CDK6 (CDK4 […]
December 1, 2018
Gerben Menschaert, Xiaojing Wang, Andrew R Jones, Fawaz Ghali, David Fenyö, Volodimir Olexiouk, Bing Zhang, Eric W Deutsch, Tobias Ternent, Juan Antonio Vizcaíno On behalf of The Human Proteome Organization (HUPO) Proteomics Standards Initiative, we introduce here two novel standard data formats, proBAM and proBed, that have been developed to address the current challenges of […]
December 1, 2018
Sherise D Ferguson 1, Siyuan Zheng 2, Joanne Xiu 3, Shouhao Zhou 4, Mustafa Khasraw 5, Priscilla K Brastianos 6, Santosh Kesari 7, Jethro Hu 8, Jeremy Rudnick 8, Michael E Salacz 9, David Piccioni 10, Suyun Huang 1, Michael A Davies 11, Isabella C Glitza 11, John V Heymach 12, Jianjun Zhang 12, Nuhad K Ibrahim 13, John F DeGroot 14, Joseph McCarty 1, Barbara J O’Brien 14, Raymond Sawaya 1, Roeland G W Verhaak 2, Sandeep K Reddy 3, Waldemar Priebe 15, Zoran Gatalica 3, David Spetzler 3, Amy B Heimberger 1 Abstract We sought to compare the tumor profiles of brain metastases from common cancers […]
November 18, 2018
Caihong Yi,Guiming Li,Dmitri N. Ivanov,Zhonghua Wang,Mitzli X. Velasco,Greco Hernández,Soni Kaundal,Johanna Villarreal,Yogesh K. Gupta ,Mei Qiao,Christopher G. Hubert,Matthew J. Hart &Luiz O.F. Penalva ABSTRACT RNA binding proteins have emerged as critical oncogenic factors and potential targets in cancer therapy. In this study, we evaluated Musashi1 (Msi1) targeting as a strategy to treat glioblastoma (GBM); the most […]
November 15, 2018
Chadia L Robertson 1, Rachel G Mendoza 1, Nidhi Jariwala 1, Mikhail Dozmorov 2 3, Nitai D Mukhopadhyay 2 3, Mark A Subler 1, Jolene J Windle 1 3, Zhao Lai 4, Paul B Fisher 1 3 5, Shobha Ghosh 6, Devanand Sarkar 7 3 5 Abstract Chronic inflammation is a known hallmark of cancer and is central to the onset and progression of hepatocellular carcinoma (HCC). Hepatic macrophages play a critical role in the inflammatory process leading to HCC. The oncogene Astrocyte […]
November 7, 2018
Sometimes small things make the biggest difference. A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene are able to kill medulloblastoma, the most common childhood brain cancer. This tiny molecule, named MiR-584-5p, is quite efficient in its action. MiR-584-5p sensitizes cancer to chemotherapy and […]
November 2, 2018
Caihong Yi, Guiming Li, Dmitri N Ivanov, Zhonghua Wang, Mitzli X Velasco, Greco Hernández, Soni Kaundal, Johanna Villarreal, Yogesh K Gupta, Mei Qiao, Christopher G Hubert, Matthew J Hart, Luiz OF Penalva RNA binding proteins have emerged as critical oncogenic factors and potential targets in cancer therapy. In this study, we evaluated Musashi1 (Msi1) targeting […]
November 1, 2018
Michael A Liss 1, James Robert White 2, Martin Goros 3, Jonathan Gelfond 3, Robin Leach 4, Teresa Johnson-Pais 4, Zhao Lai 5, Elizabeth Rourke 4, Joseph Basler 4, Donna Ankerst 4, Dimpy P Shah 3 Abstract Background: The fecal microbiome is associated with prostate cancer risk factors (obesity, inflammation) and can metabolize and produce various products that may influence cancer but have yet to be defined in prostate cancer. Objective: To investigate gut bacterial diversity, identify specific […]